Its clinics and hospitals accounted for 29% and 20% of the turnover, respectively, followed by the corporate and laboratories division, which accounted for 22% and 17%, respectively.
“This increase was mainly the result of significant growth in almost all of the Group’s business lines, led on a percentage basis by Clinics, Hospitals, Pharmacies and Laboratories, as well as the impact of the acquisitions completed by the Group in 2017 and 2018,” MedLife said in its earnings report.
The group had operating expenses of RON556 million in January-September, up 27.9% on the year.
Current debt, excluding interest bearing debt, grew by RON2.7 million at the end of September, to RON78.8 million.